| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
28,730,000 |
| Market
Cap: |
4.14(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$123.36 - $203.91 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Krystal Biotech is a clinical-stage biotechnology company focused on the development of gene therapies to improve the lives of patients living with rare diseases. Co. has developed a gene delivery platform that enables off-the-shelf treatments for serious dermatology and respiratory diseases. Co.'s platform consists of a patented, engineered viral vector derived from the herpes simplex virus type 1 (HSV-1) that it has optimized for local and repeat gene transfer to epithelial cells. Co.'s main product candidate is Beremagene geperpavec (B-VEC), which is for the treatment of dystrophic epidermolysis bullosa, a rare skin disease caused by missing or mutated mutated type VII collagen protein.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
100,000 |
200,750 |
400,750 |
843,837 |
| Total Sell Value |
$15,035,672 |
$32,946,135 |
$69,202,733 |
$133,953,905 |
| Total People Sold |
2 |
3 |
3 |
4 |
| Total Sell Transactions |
20 |
25 |
33 |
54 |
| End Date |
2025-05-22 |
2025-02-18 |
2024-08-20 |
2023-08-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Krishnan Suma |
President, R&D |
• • • |
2025-07-16 |
4 |
AS |
$150.00 |
$208,350 |
I/I |
(1,389) |
1,508,056 |
|
0% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-16 |
4 |
AS |
$150.00 |
$229,350 |
D/D |
(1,529) |
1,438,711 |
|
0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-16 |
4 |
AS |
$150.00 |
$229,350 |
I/I |
(1,529) |
1,438,711 |
|
0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-16 |
4 |
AS |
$150.00 |
$208,350 |
D/D |
(1,389) |
1,508,056 |
|
0% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-15 |
4 |
AS |
$150.68 |
$465,700 |
I/I |
(3,084) |
1,509,445 |
|
2% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-15 |
4 |
AS |
$150.68 |
$458,361 |
D/D |
(3,036) |
1,440,240 |
|
2% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-15 |
4 |
AS |
$150.68 |
$458,361 |
I/I |
(3,036) |
1,440,240 |
|
2% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-15 |
4 |
AS |
$150.68 |
$465,700 |
D/D |
(3,084) |
1,509,445 |
|
2% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-14 |
4 |
AS |
$150.30 |
$2,014,015 |
I/I |
(13,400) |
1,512,529 |
|
-0% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-14 |
4 |
AS |
$150.29 |
$2,019,225 |
D/D |
(13,435) |
1,443,276 |
|
-0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-14 |
4 |
AS |
$150.29 |
$2,019,225 |
I/I |
(13,435) |
1,443,276 |
|
-0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-14 |
4 |
AS |
$150.30 |
$2,014,015 |
D/D |
(13,400) |
1,512,529 |
|
-0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-10 |
4 |
AS |
$150.23 |
$1,021,880 |
I/I |
(6,800) |
1,456,711 |
|
0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-10 |
4 |
AS |
$150.22 |
$1,040,913 |
D/D |
(6,927) |
1,525,929 |
|
0% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-10 |
4 |
AS |
$150.22 |
$1,040,913 |
I/I |
(6,927) |
1,525,929 |
|
0% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-10 |
4 |
AS |
$150.23 |
$1,021,880 |
D/D |
(6,800) |
1,456,711 |
|
0% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-09 |
4 |
AS |
$150.14 |
$30,028 |
I/I |
(200) |
1,463,511 |
|
1% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-07-09 |
4 |
AS |
$150.07 |
$30,014 |
D/D |
(200) |
1,532,856 |
|
1% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-09 |
4 |
AS |
$150.07 |
$30,014 |
I/I |
(200) |
1,532,856 |
|
1% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-07-09 |
4 |
AS |
$150.14 |
$30,028 |
D/D |
(200) |
1,463,511 |
|
1% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-03-13 |
4 |
AS |
$175.97 |
$4,444,761 |
I/I |
(25,000) |
1,463,711 |
|
-14% |
|
| Krishnan Krish S |
President and CEO |
• • • |
2025-03-13 |
4 |
AS |
$175.83 |
$4,444,763 |
D/D |
(25,000) |
1,533,056 |
|
-14% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-03-13 |
4 |
AS |
$175.83 |
$4,444,763 |
I/I |
(25,000) |
1,533,056 |
|
-14% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-03-13 |
4 |
AS |
$175.97 |
$4,444,761 |
D/D |
(25,000) |
1,463,711 |
|
-14% |
|
| Krishnan Suma |
President, R&D |
• • • |
2025-02-28 |
4 |
D |
$179.25 |
$3,940,811 |
I/I |
(21,985) |
1,562,777 |
|
- |
|
189 Records found
|
|
Page 1 of 8 |
|
|
2.34 (1.6%) 
